Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLCO2B1 | O94956 | 4/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 3/20 | 1.00 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.86 |
| ▸ | KDM1A | O60341 | 2/20 | 0.79 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.79 |
| ▸ | GSK3B | P49841 | 3/20 | 0.79 |
| ▸ | UBE2N | P61088 | 1/20 | 0.79 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.70 |
| ▸ | P4HB | P07237 | 1/20 | 0.70 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.70 |
| ▸ | PKM | P14618 | 1/20 | 0.69 |
| ▸ | XDH | P47989 | 1/20 | 0.68 |
| ▸ | DPP4 | P27487 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.62 |
| ▸ | CALM1 | P0DP23 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.62 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Prunin SCHEMBL13904742 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL29560212 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL31233345 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL29336352 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL318230 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL1122487 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL13625098 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL31233342 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL318229 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| SCHEMBL29822818 | 0.93 | PTPN1 (0.88) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2023-06-08 | — | — | US | claimed |
| EP-4146194-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | Gretals Australia Pty Ltd (AU) | 2023-03-15 | — | — | EP | claimed |
| WO-2021222987-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2021-11-11 | — | — | WO | claimed |
| US-20210205344-A1 | COMPOSITION CONTAINING FLAVONOID-CYCLODEXTRIN CLATHRATE COMPOUND | TAIYO KAGAKU CO., LTD. (JP) | 2021-07-08 | — | — | US | claimed |
| EP-3805399-A1 | COMPOSITION CONTAINING FLAVONOID-CYCLODEXTRIN CLATHRATE COMPOUND | Taiyo Kagaku Co., Ltd. (JP) | 2021-04-14 | — | — | EP | claimed |
| CN-112236525-A | Compositions containing flavonoid-cyclodextrin inclusion compounds | 太阳化学株式会社 | 2021-01-15 | — | — | CN | claimed |
| EP-3733860-A1 | FLAVONOID INCLUSION COMPOUNDS | Taiyo Kagaku Co., Ltd. (JP) | 2020-11-04 | — | — | EP | claimed |
| US-10676496-B2 | Method for producing flavonoid inclusion compound | TAIYO KAGAKU CO., LTD. (JP) | 2020-06-09 | — | — | US | claimed |
| EP-3453766-B1 | METHOD FOR PRODUCING FLAVONOID INCLUSION COMPOUNDS | TAIYO KAGAKU KK (JP) | 2020-06-03 | — | — | EP | claimed |
| US-20200062796-A1 | METHOD FOR PRODUCING FLAVONOID INCLUSION COMPOUND | TAIYO KAGAKU CO., LTD. (JP) | 2020-02-27 | — | — | US | claimed |
| CN-110462052-A | Process for producing flavone inclusion compound | TAIYO KAGAKU KK | 2019-11-15 | — | — | CN | claimed |
| US-20190248825-A1 | METHOD FOR PRODUCING FLAVONOID INCLUSION COMPOUND | TAIYO KAGAKU CO., LTD. (JP) | 2019-08-15 | — | — | US | claimed |
| EP-3453766-A1 | METHOD FOR PRODUCING FLAVONOID CLATHRATE | Taiyo Kagaku Co., Ltd. (JP) | 2019-03-13 | — | — | EP | claimed |
| CN-103230408-B | Method for preparing phloretin | FOSHAN JINJUNKANG HEALTH SCIENCE AND TECHNOLOGY CO., LTD. (CN) | 2014-10-22 | — | — | CN | claimed |
| CN-103230408-A | Method for preparing phloretin | FOSHAN JINJUNKANG HEALTH SCIENCE AND TECHNOLOGY CO LTD | 2013-08-07 | — | — | CN | claimed |
| US-20090253616-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2009-10-08 | — | — | US | claimed |
| EP-2026808-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | AstraZeneca AB (SE) | 2009-02-25 | — | — | EP | claimed |
| WO-2007132215-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2007-11-22 | — | — | WO | claimed |
| EP-0314959-B1 | SELECTIVE HYDROLYSIS | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 1992-05-27 | — | — | EP | claimed |
| EP-0314959-A1 | Selective hydrolysis | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 1989-05-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190248825-A1 | METHOD FOR PRODUCING FLAVONOID INCLUSION COMPOUND | MGAM, SI, MANBA | SLCO2B1 2397/4885PTPN1 2973/4885SYNJ2 1630/4885 |
| US-20090253616-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | AURKC, AURKB, AURKA | SLCO2B1 64/4885PTPN1 2673/4885SYNJ2 2445/4885 |
| US-10676496-B2 | Method for producing flavonoid inclusion compound | MGAM, SI, MANBA | SLCO2B1 2397/4885PTPN1 2973/4885SYNJ2 1630/4885 |
| US-20200062796-A1 | METHOD FOR PRODUCING FLAVONOID INCLUSION COMPOUND | MGAM, SI, MANBA | SLCO2B1 2397/4885PTPN1 2973/4885SYNJ2 1630/4885 |
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | MMP1, COL1A1, SERPINB1 | SLCO2B1 3287/4885PTPN1 2926/4885SYNJ2 1598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.